High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma

Jeffrey K. Wang, Matthew K. Tollefson, Amy E. Krambeck, Landon W. Trost, R. Houston Thompson

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Objective: To determine the association between endoscopic biopsy grade and the final pathologic characteristics at nephroureterectomy for upper tract urothelial carcinoma (UTUC). Endoscopic biopsy is an important tool for patients with UTUC because the results can influence the management decisions. Methods: We identified 481 patients who had undergone nephroureterectomy for UTUC at the Mayo Clinic from 1995 to 2008. Of these patients, 184 underwent endoscopic cup or brush biopsy before nephroureterectomy. The biopsy tumor grade was then compared with the tumor grade and stage obtained at nephroureterectomy. Results: Of the 184 patients, 27 (15%) had nondiagnostic biopsy results and 21 (11%) had positive biopsy results with no histologic grade. Of the 24 patients with grade 1 tumors on biopsy, 23 (96%) had the tumor upgraded on the final pathologic examination: 16 (67%) to grade 2 and 7 (29%) to grade 3. Similarly, 23 (40%) of 57 grade 2 tumors on biopsy were upgraded to grade 3 after nephrouretecomy. Only a few patients, 7 (4%) of 184, were found to have a lower histologic grade on the final pathologic examination. The number of patients with invasive UTUC for endoscopic grade 1, 2, and 3 tumors was 9 (38%) of 24, 31 (54%) of 57, and 47 (85%) of 55, respectively. Conclusion: In the context of patients selected for nephroureterectomy, we observed a greater than expected rate of tumor upgrading and invasive disease, particularly in those with low-grade tumors at biopsy. These findings should be considered when electing to use conservative or endoscopic management of low-grade UTUC.

Original languageEnglish (US)
Pages (from-to)615-619
Number of pages5
JournalUrology
Volume79
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Carcinoma
Biopsy
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Wang, J. K., Tollefson, M. K., Krambeck, A. E., Trost, L. W., & Thompson, R. H. (2012). High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. Urology, 79(3), 615-619. https://doi.org/10.1016/j.urology.2011.11.049

High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. / Wang, Jeffrey K.; Tollefson, Matthew K.; Krambeck, Amy E.; Trost, Landon W.; Thompson, R. Houston.

In: Urology, Vol. 79, No. 3, 03.2012, p. 615-619.

Research output: Contribution to journalArticle

Wang, JK, Tollefson, MK, Krambeck, AE, Trost, LW & Thompson, RH 2012, 'High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma', Urology, vol. 79, no. 3, pp. 615-619. https://doi.org/10.1016/j.urology.2011.11.049
Wang, Jeffrey K. ; Tollefson, Matthew K. ; Krambeck, Amy E. ; Trost, Landon W. ; Thompson, R. Houston. / High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma. In: Urology. 2012 ; Vol. 79, No. 3. pp. 615-619.
@article{11bbbb413db945aa919e097ae73d73c1,
title = "High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma",
abstract = "Objective: To determine the association between endoscopic biopsy grade and the final pathologic characteristics at nephroureterectomy for upper tract urothelial carcinoma (UTUC). Endoscopic biopsy is an important tool for patients with UTUC because the results can influence the management decisions. Methods: We identified 481 patients who had undergone nephroureterectomy for UTUC at the Mayo Clinic from 1995 to 2008. Of these patients, 184 underwent endoscopic cup or brush biopsy before nephroureterectomy. The biopsy tumor grade was then compared with the tumor grade and stage obtained at nephroureterectomy. Results: Of the 184 patients, 27 (15{\%}) had nondiagnostic biopsy results and 21 (11{\%}) had positive biopsy results with no histologic grade. Of the 24 patients with grade 1 tumors on biopsy, 23 (96{\%}) had the tumor upgraded on the final pathologic examination: 16 (67{\%}) to grade 2 and 7 (29{\%}) to grade 3. Similarly, 23 (40{\%}) of 57 grade 2 tumors on biopsy were upgraded to grade 3 after nephrouretecomy. Only a few patients, 7 (4{\%}) of 184, were found to have a lower histologic grade on the final pathologic examination. The number of patients with invasive UTUC for endoscopic grade 1, 2, and 3 tumors was 9 (38{\%}) of 24, 31 (54{\%}) of 57, and 47 (85{\%}) of 55, respectively. Conclusion: In the context of patients selected for nephroureterectomy, we observed a greater than expected rate of tumor upgrading and invasive disease, particularly in those with low-grade tumors at biopsy. These findings should be considered when electing to use conservative or endoscopic management of low-grade UTUC.",
author = "Wang, {Jeffrey K.} and Tollefson, {Matthew K.} and Krambeck, {Amy E.} and Trost, {Landon W.} and Thompson, {R. Houston}",
year = "2012",
month = "3",
doi = "10.1016/j.urology.2011.11.049",
language = "English (US)",
volume = "79",
pages = "615--619",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - High rate of pathologic upgrading at nephroureterectomy for upper tract urothelial carcinoma

AU - Wang, Jeffrey K.

AU - Tollefson, Matthew K.

AU - Krambeck, Amy E.

AU - Trost, Landon W.

AU - Thompson, R. Houston

PY - 2012/3

Y1 - 2012/3

N2 - Objective: To determine the association between endoscopic biopsy grade and the final pathologic characteristics at nephroureterectomy for upper tract urothelial carcinoma (UTUC). Endoscopic biopsy is an important tool for patients with UTUC because the results can influence the management decisions. Methods: We identified 481 patients who had undergone nephroureterectomy for UTUC at the Mayo Clinic from 1995 to 2008. Of these patients, 184 underwent endoscopic cup or brush biopsy before nephroureterectomy. The biopsy tumor grade was then compared with the tumor grade and stage obtained at nephroureterectomy. Results: Of the 184 patients, 27 (15%) had nondiagnostic biopsy results and 21 (11%) had positive biopsy results with no histologic grade. Of the 24 patients with grade 1 tumors on biopsy, 23 (96%) had the tumor upgraded on the final pathologic examination: 16 (67%) to grade 2 and 7 (29%) to grade 3. Similarly, 23 (40%) of 57 grade 2 tumors on biopsy were upgraded to grade 3 after nephrouretecomy. Only a few patients, 7 (4%) of 184, were found to have a lower histologic grade on the final pathologic examination. The number of patients with invasive UTUC for endoscopic grade 1, 2, and 3 tumors was 9 (38%) of 24, 31 (54%) of 57, and 47 (85%) of 55, respectively. Conclusion: In the context of patients selected for nephroureterectomy, we observed a greater than expected rate of tumor upgrading and invasive disease, particularly in those with low-grade tumors at biopsy. These findings should be considered when electing to use conservative or endoscopic management of low-grade UTUC.

AB - Objective: To determine the association between endoscopic biopsy grade and the final pathologic characteristics at nephroureterectomy for upper tract urothelial carcinoma (UTUC). Endoscopic biopsy is an important tool for patients with UTUC because the results can influence the management decisions. Methods: We identified 481 patients who had undergone nephroureterectomy for UTUC at the Mayo Clinic from 1995 to 2008. Of these patients, 184 underwent endoscopic cup or brush biopsy before nephroureterectomy. The biopsy tumor grade was then compared with the tumor grade and stage obtained at nephroureterectomy. Results: Of the 184 patients, 27 (15%) had nondiagnostic biopsy results and 21 (11%) had positive biopsy results with no histologic grade. Of the 24 patients with grade 1 tumors on biopsy, 23 (96%) had the tumor upgraded on the final pathologic examination: 16 (67%) to grade 2 and 7 (29%) to grade 3. Similarly, 23 (40%) of 57 grade 2 tumors on biopsy were upgraded to grade 3 after nephrouretecomy. Only a few patients, 7 (4%) of 184, were found to have a lower histologic grade on the final pathologic examination. The number of patients with invasive UTUC for endoscopic grade 1, 2, and 3 tumors was 9 (38%) of 24, 31 (54%) of 57, and 47 (85%) of 55, respectively. Conclusion: In the context of patients selected for nephroureterectomy, we observed a greater than expected rate of tumor upgrading and invasive disease, particularly in those with low-grade tumors at biopsy. These findings should be considered when electing to use conservative or endoscopic management of low-grade UTUC.

UR - http://www.scopus.com/inward/record.url?scp=84863289858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863289858&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2011.11.049

DO - 10.1016/j.urology.2011.11.049

M3 - Article

C2 - 22386411

AN - SCOPUS:84863289858

VL - 79

SP - 615

EP - 619

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -